Correlation Between CorMedix and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both CorMedix and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CorMedix and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CorMedix and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on CorMedix and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CorMedix with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CorMedix and Tarsus Pharmaceuticals.
Diversification Opportunities for CorMedix and Tarsus Pharmaceuticals
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between CorMedix and Tarsus is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding CorMedix and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and CorMedix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CorMedix are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of CorMedix i.e., CorMedix and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between CorMedix and Tarsus Pharmaceuticals
Given the investment horizon of 90 days CorMedix is expected to generate 1.29 times less return on investment than Tarsus Pharmaceuticals. In addition to that, CorMedix is 1.06 times more volatile than Tarsus Pharmaceuticals. It trades about 0.06 of its total potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.08 per unit of volatility. If you would invest 1,779 in Tarsus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 3,045 from holding Tarsus Pharmaceuticals or generate 171.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
CorMedix vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| CorMedix |
| Tarsus Pharmaceuticals |
CorMedix and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CorMedix and Tarsus Pharmaceuticals
The main advantage of trading using opposite CorMedix and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CorMedix position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| CorMedix vs. Tarsus Pharmaceuticals | CorMedix vs. Aldeyra | CorMedix vs. Travere Therapeutics | CorMedix vs. Eton Pharmaceuticals |
| Tarsus Pharmaceuticals vs. Capricor Therapeutics | Tarsus Pharmaceuticals vs. Soleno Therapeutics | Tarsus Pharmaceuticals vs. Bio Path Holdings | Tarsus Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |